Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary pathogen of enzootic pneumonia, a chronic respiratory disease in pigs. Infections occur worldwide and cause major economic losses to the pig industry. The present paper reviews the current knowledge on M. hyopneumoniae infections, with emphasis on identification and analysis of knowledge gaps for optimizing control of the disease. Close contact between infected and susceptible pigs is the main route of M. hyopneumoniae transmission. Management and housing conditions predisposing for infection or disease are known, but further research is needed to better understand M. hyopneumoniae transmission patterns in modern pig production systems, and to assess the impor- 
| INTRODUCTION
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary pathogen of enzootic pneumonia (EP), a chronic respiratory disease in pigs, and one of the primary agents involved in the porcine respiratory disease complex (PRDC; Thacker & Minion, 2012) . Infections with M. hyopneumoniae are highly prevalent worldwide and cause tremendous financial losses to the pig industry. Losses are mainly due to costs for treatment and vaccination, decreased performance and increased mortality derived from secondary infections (Holst, Yeske, & Pieters, 2015) .
Similar to other Mycoplasmas, M. hyopneumoniae has a small genome, lacks a cell wall and is pleomorphic. M. hyopneumoniae is very difficult to isolate because of its slow growth and potential overgrowth with other swine mycoplasmas. Bacterial culture is usually attempted when an isolate is deemed, but not for routine diagnostics. The organism is primarily identified on the mucosal surface of the trachea, bronchi and bronchioles (Blanchard et al., 1992) . It affects the mucosal clearance system by disrupting the cilia on the epithelial surface, and additionally, the organism modulates the immune system of the respiratory tract (Thacker & Minion, 2012) .
Therefore, M. hyopneumoniae predisposes animals to concurrent infections with other respiratory pathogens including bacteria, parasites and viruses. Infections also lead to increased use of antimicrobials. While M. hyopneumoniae can be virtually recovered from pigs of all sites in segregated production systems, the clinical presentation of EP is mainly observed in growing and finishing pigs. Vaccination against M. hyopneumoniae is widely practiced and is often costefficient in affected herds. Additional control measures include optimizing management and biosecurity, reducing other risk factors and disease elimination.
The present paper reviews the current knowledge on M. hyopneumoniae infections, with emphasis on identification and analysis of knowledge gaps for optimizing control measures.
| EPID EMIOLOGY
To date, domestic pigs and wild boar are the only hosts known to become infected with M. hyopneumoniae. In pigs, there is no clear indication of susceptibility based on age, although clinical presentation of the disease is usually evident in grow-finishing stages. Close contact between infected and susceptible pigs is the main route of M. hyopneumoniae transmission. Piglets are considered free from M. hyopneumoniae at birth, as in utero transmission has not been documented, and first exposure events occur during the lactation period, when piglets are in contact with dams shedding the microorganism (Calsamiglia & Pijoan, 2000; Nathues et al., 2013a,b) . In fact, the length of the lactation period has been suggested as one risk factor for piglet colonization with M. hyopneumoniae prior to weaning (Pieters et al., 2014) .
Piglet colonization with M. hyopneumoniae at weaning age is of special importance in segregated production systems, where pigs are transferred to clean facilities for the growing and finishing phases. It has been proposed that the initial group colonization with M. hyopneumoniae determines downstream clinical presentation and disease severity (Fano, Pijoan, Dee, & Deen, 2007; Sibila et al., 2007) , although the effect of other factors needs to be considered for disease presentation as well. The influence of the lactation period duration in piglet colonization is evidenced by the successful application of segregated early weaning (SEW) to obtain M. hyopneumoniae-free pigs born to positive dams (Alexander, Thornton, Boon, Lysons, & Gush, 1980) . Research data have shown that transmission of M. hyopneumoniae among pen-mates is slow (Meyns et al., 2004; Roos, Fano, Homwong, Payne, & Pieters, 2016; Villarreal et al., 2011b) , fitting the picture that disease presentation can be the result of early group colonization and subsequent transmission events. However, a clear understanding of M. hyopneumoniae transmission in the field is still needed to improve infection models used in experimental research.
Dams and piglets in the breeding herds are considered the reservoir of M. hyopneumoniae infections for the entire production system. Circulation of M. hyopneumoniae is thought to occur among existing sows and be transmitted to incoming gilts, which are capable of maintaining the pathogen within the farm and are responsible for the majority of bacterial shedding to newborn pigs (Calsamiglia & Pijoan, 2000; Fano, Pijoan, & Dee, 2005) . In this manner, the constant addition of gilts and birth of piglets provide critical susceptible populations needed to maintain pathogen transmission. On the other hand, infection with M. hyopneumoniae has a long duration, reaching up to 240 days (Pieters, Pijoan, Fano, & Dee, 2009) , complicating the already slow disease transmission scenario observed in sow herds. A critical aspect of the epidemiology of M. hyopneumoniae is based on the long pathogen persistence, which determining factors are poorly understood. Nevertheless, management practices at the sow farm such as minimizing cross-fostering and limiting the length of the lactation period may help mitigating the effect of M. hyopneumoniae transmission by decreasing risk factors for piglet colonization (Nathues et al., 2013a,b; Pieters et al., 2014; Vangroenweghe, Labarque, Piepers, Strutzberg-Minder, & Maes, 2015) . Therefore, identification of risk factors for disease transmission at the sow farm is key for downstream disease control. In continuous-flow production systems, M. hyopneumoniae colonization in piglets at weaning may not be as influential as in segregated systems. In continuous-flow systems, there is a fairly constant contact between animals of different ages, facilitating transmission of M. hyopneumoniae. In this respect, the colonization of piglets at weaning is not the only determining factor for downstream infection.
An additional source of variability regarding epidemiology of M. hyopneumoniae lies on the demonstration of distinct strains circulating in the field. Partial sequencing of the P146 gene (Mayor, Zeeh, Frey, & Kuhnert, 2007) and multiple-locus variable number tandem repeat analysis (MLVA; Vranckx et al., 2011; Dos Santos et al., 2015) are commonly used to discriminate M. hyopneumoniae. The use of M. hyopneumoniae molecular characterization has aided outbreak and area spread investigations, by tracking specific strains. In MAES ET AL.
| 111 addition, it has enabled research directed at understanding pathogen variability and its relationship with disease presentation (Michiels et al., 2017 ). However, current tools for M. hyopneumoniae characterization are based on the sole evaluation of similarities in specific loci and do not indicate strain virulence and/or antigenicity. Development of molecular characterization methods allowing strain virulence evaluation would be beneficial to tailor control strategies at the farm level and could shed light on understanding potential crossprotection among strains.
Vectors do not seem to play an important role in the transmission of M. hyopneumoniae in pigs; however, little research has been performed on this topic. Data from Nathues et al. (2012) showed that personnel working with pigs for several hours could harbour the bacterium in their upper respiratory tract, as detected via PCR in nasal swabs; however, the potential for pathogen transmission was not evaluated. Airborne transmission of M. hyopneumoniae has been suspected for decades (Goodwin, 1985) . Cardona, Pijoan, and Dee (2005) demonstrated that the microorganism could travel for at least 300 m, and Otake, Dee, Corzo, Oliveira, and Deen (2010) showed that air samples recovered M. hyopneumoniae DNA from as far as 9.2 km from an infected farm. In the latter case, the air sample was shown to be infectious when inoculated to animals using a swine bioassay.
The geographical distribution of M. hyopneumoniae infections is assumed to be worldwide. The prevalence is low in some Scandinavian countries, and Switzerland is free after the application of a national eradication programme (St€ ark et al., 2007) . Specific data on M. hyopneumoniae prevalence by country are not available in the literature, as the disease is not considered of obligatory report and does not limit commercial trade.
Wild boar has been shown to harbour M. hyopneumoniae and may carry identical genotypes found in EP outbreaks (Kuhnert & Overesch, 2014; Sibila et al., 2010) . However, this might be rather the result of spillover from domestic pig outbreaks than representing wild boars as a reservoir.
| INCUBATION PERIOD AND KINETIC

PATTE RN
Under experimental conditions, where usually seronegative animals are challenged with a high infectious dose of M. hyopneumoniae, lung lesions and onset of coughing can appear as early as 7-14 days post-infection (dpi; Blanchard et al., 1992; Lorenzo, Quesada, Assuncao, Castro, & Rodr ıguez, 2006) , with maximum severity and extension of lung lesions occurring around 28 dpi (Villarreal et al., 2011a) . The minimal infectious dose to induce lung lesions was established at 10 5 colour-changing units per ml (CCU/ml) per pig (corresponding to 10 8 mycoplasmas; Marois, Dory, Fablet, Madec, & Kobisch, 2010) . As differences in virulence among strains do exist, this minimal infectious dose is probably strain dependent.
Under natural conditions, the incubation period is difficult to predict as it depends on production system, presence of secondary infections, immune status of animals, virulence of the M. hyopneumoniae strain and infectious pressure (Sibila et al., 2009 ). Indeed, it was postulated that a critical mass of pigs should be infected to elicit the appearance of clinical signs (Calsamiglia, Pijoan, & Trigo, 1999 Mycoplasma hyopneumoniae is excreted from the respiratory tract of infected individuals through exhalation of microscopic droplets during coughing episodes and/or by nose-to-nose direct contact (Hermann, Brockmeier, Yoon, & Zimmerman, 2008) .
M. hyopneumoniae DNA has also been detected in different samples from the oral cavity such as oropharyngeal swabs (Fablet, Marois, Kobisch, Madec, & Rose, 2010; Hermann et al., 2008) , oral fluids (Roos et al., 2016) and tonsillar samples Sibila et al., 2007) .
It is known that sows of different parity number may shed the organism, the younger ones being the main shedders (Boonsoongnern, Jirawattanapong, & Lertwatcharasarakul, 2012; Sibila et al., 2007) . Practices directed at segregation of parity, giving special care to parity-one dams and piglets and separating them from the rest of the herd, have been reported to provide significant control of M. hyopneumoniae infections in young parity dams (Moore, 2003) . Nonetheless, it remains unclear whether this excretion is uniform and continuous or, on the contrary, is of variable intensity and intermittent. An experimental longitudinal study showed the onset of excretion at 7-14 dpi, followed by an irregular and inconsistent shedding (detection of M. hyopneumoniae DNA at nasal cavities) up to 91 dpi (Fano et al., 2005) . Indeed, longer excretion was indirectly demonstrated by the transmissibility of M. hyopneumoniae to na€ ıve contact pigs at 214 dpi . Under natural conditions, shedding duration and kinetics are more difficult to be ascertained, as a low bacterial load is usually present at upper respiratory tract sites (Hermann et al., 2008; Sibila et al., 2009) . In a study where M. hyopneumoniae detection was assessed in nasal swabs at nine sampling points through the productive life of pigs, two of 33 (6%) non-vaccinated animals were continuously nested PCR positive in the last five sampling points (from 12 to 25 weeks of age; Sibila et al., 2007) . On the contrary, in a longitudinal study in sows, only 2.4% of them had at least one of the three assessed respiratory sites (nasal, tonsillar and oropharyngeal swabs) positive by PCR. For all these positive sows, M. hyopneumoniae was detected at one of eight sampling occasions (Fablet et al., 2011 4 | PATHOGENICITY
| Adhesins and lipoproteins
Adhesion along the entire length of cilia of ciliated epithelium of the respiratory tract (trachea, bronchi and bronchioles) of pigs is the first step of infection with M. hyopneumoniae followed by induction of ciliostasis and loss of cilia (Debey & Ross, 1994) . The primary adhesin of M. hyopneumoniae is the P97 and its paralogues (Hsu & Minion, 1998) . The other family of adhesins, related with P97, is formed by P102 and its paralogues (Adams, Pitzer, & Minion, 2005) . Finally, P159 is an adhesin unrelated to the other two (Burnett et al., 2006) .
Adhesin receptors on the eukaryotic cell are mainly glycosaminoglycans and fibronectin. Most of the proteins from the P97/P102 paralogue families and P159 are post-translationally processed and cleaved, a system observed with many other surface-associated proteins (Seymour et al., 2010) . Like that, Tacchi P146 (LppS) is an adhesion lipoprotein containing a serine-rich region, the genetic basis of it is also used for genotyping (Mayor et al., 2007) . The homolog in Mycoplasma conjunctivae was hypothesized to be involved in pathogenesis, and in M. hyopneumoniae, it is also proteolytically processed (Belloy, Vilei, Giacometti, & Frey, 2003; Bogema et al., 2012) . This together with the fact that M. hyopneumoniae can alter the number of consecutive serine repeats in P146 (so far observed from 9 up to 48) could indicate that it is also involved in antigen variation and immune evasion (Dos Santos et al., 2015) .
Cell-surface lipoproteins, alternatively called lipid-associated membrane proteins (LAMP), have also been found to be implicated in apoptosis. Whole membrane lipoprotein fractions were shown to induce apoptosis via caspases 3 and 8 activation in vitro in various cell types, including porcine peripheral blood mononuclear cells (PBMC; Bai et al., 2015; Ni et al., 2015) . Furthermore, LAMPs activate production of nitric oxide (NO) and reactive oxygen species (ROS) in the host cell.
| H 2 O 2 production
Mycoplasmas in general lack classical virulence factors like toxins. It has remained obscure for a long time how these smallest self-replicating organisms could elicit toxic effects. Recently, the production of toxic metabolites like H 2 O 2 was found as a virulence mechanism of certain mycoplasma species. The bovine pathogen Mycoplasma mycoides subsp. mycoides SC is able to take up glycerol efficiently, Thus, whether production of toxic metabolic compounds from glycerol is a possible virulence mechanism in M. hyopneumoniae remains to be investigated.
| Comparative studies with other Mycoplasmas
Differences in strain virulence have been observed for M. hyopneumoniae (Vicca et al., 2003; Villarreal et al., 2009; Woolley et al., 2012; ) . Moreover, the most closely related Mycoplasma flocculare is a commensal of the pig not causing any disease (Siqueira et al., 2013) .
This allows for large-scale comparisons on the genome, transcriptome, proteome, metabolome and secretome level in order to find differences related to virulence and pathogenesis (Ferrarini et al., 2016; Liu et al., 2013; Paes et al., 2017; Pinto, Klein, Zaha, & Ferreira, 2009; Siqueira et al., 2013 Siqueira et al., , 2014 . In a study comparing the pathogenic strain 168 with its attenuated derivative, Liu et al. (2013) found that besides the known virulence-associated proteins (mainly adhesins), also mutations in genes involved in metabolism and growth contribute to virulence. In a genome-reduced organism like M. hyopneumoniae that lost most of its biosynthetic capacity, it is not surprising that further loss of gene functions has a dramatic influence on survival and growth of the microorganism. This also holds true for, for example, lipoproteins involved in nutrient acquisition (Browning, Marenda, Noormohammadi, & Markham, 2011) . Nevertheless, such attenuated strains could be a basis for live vaccines.
A genome comparison of M. hyopneumoniae and M. flocculare revealed differences in genome structure and organization (Siqueira et al., 2013) . Some genes of the P97 adhesin family were absent in M. flocculare, showed sequence differences or were missing domains involved in adhesion to host cells. However, there were no specific factors identified that could explain the pathogenic nature of M. hyopneumoniae compared to the commensal M. flocculare.
An integrative conjugal element (ICE) has been identified in the genomes of pathogenic strains 7448 and 232, while it is absent in the non-pathogenic strain J (Pinto, de Carvalho, Alves-Junior, Brocchi, & Schrank, 2007) . The ICE from M. hyopneumoniae, called ICEH, was also found in the pathogenic strain 168 but likewise in its attenuated variant (Liu et al., 2013) . While ICE, acting as self-replicating mobile genetic elements, is generally recognized to be involved in virulence, their role in the pathogenicity of M. hyopneumoniae remains unclear. The fact that there are notable differences of ICEH between the strains indicates that they are at least involved in horizontal gene transfer, thereby maintaining genome plasticity and variability of M. hyopneumoniae.
Ferrarini et al. (2016) used a genome-scale metabolic modelling
approach to get insight into the virulence of M. hyopneumoniae.
Besides a glycerol conversion pathway potentially leading to peroxide production in M. hyopneumoniae, another significant metabolic pathway was identified to be absent in M. flocculare which is the myoinositol uptake and catabolism. Functional and in vivo assays have to be conducted to proof whether these in silico findings play a role in virulence and pathogenicity.
Differences in virulence could also be due to variation in expression levels of virulence-associated genes like adhesins. This was observed in a proteome analysis of in vitro cultures comparing the non-pathogenic strain J to virulent strains 7448 and 7422 (Pinto et al., 2009 ). They identified 64 proteins being overexpressed in the pathogenic strains compared to the non-pathogenic strain, the most prominent being P97.
Finally, the secretomes of M. hyopneumoniae and M. flocculare grown in a serum-reduced medium were compared recently, looking more precisely at factors directly involved in mycoplasma-host interaction (Paes et al., 2017) . A higher number of secreted proteins were found with M. hyopneumoniae compared to M. flocculare (62 versus 26). While M. hyopneumoniae secreted adhesins, methylases, nucleases and lipoproteins, M. flocculare secreted only two adhesins that were also found in the M. hyopneumoniae secretome. There was a difference between the transcriptome and the secretome using the same mycoplasma strains (Siqueira et al., 2014) .
These comparative "omics" studies confirmed that adhesins play a major role in virulence and pathogenesis. However, there are no clear-cut factors that differ between pathogenic and non-pathogenic strains or differ between the pathogen M. hyopneumoniae and the commensal M. flocculare.
| Mycoplasma-host interaction and immune modulation
Infection with M. hyopneumoniae is often chronic what indicates a certain degree of immune evasion of the microbe. In a study looking at introgression of domestic swine genes into the wild boar population, an increased M. hyopneumoniae disease susceptibility in hybrid animals was observed (Goedbloed et al., 2015) . The authors hypothesized that the large-scale use of antibiotics in the swine breeding sector may have led to selecting deleterious properties of domestic swine immune genes. These in turn lead to the increased disease susceptibility if introgression to the wild boar occurs. These observations confirm a certain host predisposition for M. hyopneumoniae which in the opposite direction can also be achieved by selecting for more resistant breeds (Borjigin et al., 2016) . Furthermore, it indicates certain "immune degeneration" of domestic pigs, allowing M. hyopneumoniae to cause disease in a well-protected animal. The destruction of the mucociliary apparatus together with down-modulating the immune response at later stages enhances the susceptibility of M. hyopneumoniae-infected pigs to secondary pathogens (Shen, Hu, Wei, Feng, & Yang, 2017) .
The host immune response is considered to be the main driver of pulmonary lesions. At the same time, M. hyopneumoniae modulates the immune response to persist in the host. Pro-inflammatory cytokines such as IL-1, TNF-a and IL-6 are induced during infection, and plasmin is recognized as central to the regulation of inflammatory responses (Woolley, Fell, Djordjevic, Eamens, & Jenkins, 2013) .
A number of the P97/P102 adhesin family members interact with plasminogen of the porcine host and enhance its activation to plasmin, a serine protease which in turn stimulates macrophage signalling resulting in production of ROS and cytokine release, thereby contributing to inflammation (Syrovets, Lunov, & Simmet, 2012) . A leucine aminopeptidase has recently been shown to "moonlight" as a multifunctional adhesin, including binding and cleaving of plasminogen, on the M. hyopneumoniae cell surface (Jarocki et al., 2015) . Plasminogen is readily available in the ciliated airways affected by M. hyopneumoniae .
Interaction with surface accessible actin on the epithelial cells and causing cytoskeletal rearrangements allows the organism being phagocytosed. It is hypothesized that M. hyopneumoniae can survive within the phagolysosome, escape it and reside within the cytoplasm (Tacchi et al., 2016) . Therefore, it can not only evade the immune system but could disseminate to internal organs and persist within 
| CLINICAL SIGN S AND LESIONS
Infections with M. hyopneumoniae are clinically characterized by an intermittent, variable in intensity, dry non-productive cough (Sibila et al., 2009) , which may last from weeks to months. When this type of coughing affects simultaneously many animals of different ages, also other pathogens such as SIV or PRRSV may be involved in the problem (Nathues et al., 2012) . Under an endemic scenario, disease course implies high morbidity but low mortality. When M. hyopneumoniae enters into a na€ ıve population, the disease may be more severe, affecting animals of all ages and increasing the morbidity up to 100% (Thacker & Minion, 2012) . If other bacterial and/or viral agents are involved, or in case of poor air quality due to particulate matter and ammonia (Michiels et al., 2015) , clinical signs may be aggravated including laboured breathing, pyrexia, anorexia, lethargy and even death (Maes, Verdonck, Deluyker, & de Kruif, 1996) . In uncomplicated cases, a variable proportion of animals might remain subclinically infected for several weeks (Fano et al., 2005) , with no evidence of coughing or pulmonary lesions at slaughter.
Coughing is the direct consequence of the lung lesions observed in affected animals, which consist of purple to grey consolidated areas affecting the apical and middle lobes and, eventually, cranial 
| SOCIO-ECONOMIC IMPACT
Mycoplasma hyopneumoniae is a species-specific pathogen of suids.
Therefore, it is not of zoonotic concern and no impact on public
health is considered. However, infections with M. hyopneumoniae cause major economic losses to the pig industry, mainly because of reduced performance, uneven growth, increased number of days to reach slaughter weight, treatment and control costs, and increased mortality in case of complicated infections (Holst et al., 2015) .
Unfortunately, few updated information on the economic impact of EP is available, and existing data have been mostly generated by assessing the relationship between evaluation of lung lesions at slaughterhouse with average daily weight gain (ADWG). Whereas a reduction of 6%-16% in the growth rate in finishing pigs was reported by some authors (Pointon et al., 1985 , Rautiainen, Virtala, Wallgren, & Saloniemi, 2000 , Circulating antibodies (IgG) can be detected in pigs exposed to M. hyopneumoniae. Antibodies are developed several weeks after initial infection (Thacker & Minion, 2012) , can be the result of maternal antibody absorption in piglets (Bandrick, Pieters, Pijoan, & Molitor, 2008) or can be generated after vaccination (Maes et al., 2008) . Thongkamkoon et al., 2013; Vicca et al., 2007) . The susceptibility to valnemulin and tiamulin may have decreased in the period 1997 (Hannan et al., 1997) to 2013 (Tavio et al., 2014; Thongkamkoon et al., 2013) . However, taken together, acquired antimicrobial resistance does currently not seem to constitute a major problem for treatment of M. hyopneumoniae infections (Klein et al., 2017) , although the situation may be different for other bacteria complicating these infections. Finally, within a farm, strains with differences in antibiotic susceptibility may coexist (Thongkamkoon et al., 2013) . 
| Vaccines
Vaccination is widely applied worldwide to control M. hyopneumoniae infections. Commercial vaccines mostly consist of inactivated, adjuvanted whole-cell preparations that are administered intramuscularly (Maes et al., 2008) . Table 1 gives an overview of different commercially available M. hyopneumoniae bacterin vaccines.
Recently, an inactivated vaccine based on soluble antigens of M. hyopneumoniae is also commercially available (USA: Fostera PCV MH, Zoetis; in Europe: Suvaxyn Circo + MH RTU, Zoetis). It is a one-shot vaccine combined with PCV2 that can be administered to piglets from 3 weeks of age onwards. In addition, attenuated vaccines against M. hyopneumoniae have been licensed in China (Feng et al., 2013) and Mexico. The vaccine in Mexico is a thermosensitive mutant of M. hyopneumoniae (VaxSafe MHYO, Avimex).
Vaccination reduces clinical signs and lung lesions and improves performance. Also, commercial vaccines reduce the number of organisms in the respiratory tract (Meyns et al., 2006; Vranckx et al., 2012b) and decrease the infection level in a herd (Sibila et al., 2007) .
However, studies under experimental (Meyns et al., 2006) and field conditions (Pieters, Fano, Pijoan, & Dee, 2010; Villarreal et al., 2011b) showed that vaccination conferred only a limited reduction in the transmission ratio of M. hyopneumoniae. antibodies on vaccine responses in piglets is not fully elucidated. Martelli, Terrini, Guazzetti, and Cavirani (2006) showed that passively acquired antibodies have little or no effect on either a vaccine-induced priming or subsequent anamnestic response.
MAES ET AL.
| 117 Sibila et al. (2008) and Arsenakis, Michiels, Boyen, Haesebrouck, and Maes (2017b) showed that vaccination of sows at the end of gestation resulted in a lower number of M. hyopneumoniae colonized piglets at weaning. Breeding gilt vaccination is recommended in endemically infected herds to avoid destabilization of the breeding stock immunity (Bargen, 2004) .
Constant effort is being directed towards the investigation of new vaccines that may offer a better protection against M. hyopneumoniae infections. In one study (Villarreal et al., 2009) 
| ELIMINATION
Successful elimination of M. hyopneumoniae from swine herds has been reported over decades (reviewed by Holst et al., 2015) , and several protocols have been developed. Besides depopulation and repopulation, initial efforts for disease elimination were based on the Swiss method (Zimmermann, Odermatt, & Tschudi, 1989) . This method includes partial depopulation (i.e., culling of all animals younger than 10 months of age) and whole herd medication, along with a 2-week farrowing pause towards the end of the protocol.
While this method has proven highly successful, its application in large herds is difficult. Thus, other protocols such as herd closure and medication, and whole herd medication, keeping young animals at the farms and piglet production undisturbed, have been developed (Holst et al., 2015) . The herd closure and medication strategy allows for the introduction of replacement gilts at the beginning of the process, relies on early exposure of the incoming females, and calls for no further introduction of susceptible animals for a period of at least 240 days, or when pathogen persistence has no longer been observed after initial infection ). In addition, quarterly mass vaccination is included as part of herd closure for disease elimination. On the other hand, the whole herd medication protocol is usually applied after clinical outbreaks of the disease and does not require the culling of animals or pause in farrowing. However, the reported success of disease elimination is lower for this protocol compared to herd closure (Holst et al., 2015) .
Although elimination of M. hyopneumoniae is becoming increasingly common in the USA, several aspects of the protocols and the potential success could be questioned. For example, concerns exist on the likelihood to eliminate M. hyopneumoniae in high pig-dense areas due to potential lateral infection of the herd, although this does not seem to occur frequently. Scientific information on lateral transmission of M. hyopneumoniae infections is largely missing, and previous evidence of pathogen airborne transmission can make a difficult case otherwise (Goodwin, 1985; Otake et al., 2010) . Also, refinement of the elimination protocols is necessary for practicality * 34 previously uncharacterized recombinant proteins of M. hyopneumoniae were evaluated in this study. ** Intramuscularly *** Subcutaneously **** Intranasal and application in combination with other disease elimination programmes. Nevertheless, elimination of M. hyopneumoniae from commercial herds, whether alone or in combination with the elimination of other pathogens, appears to be justified from the ethical and economical points of view (Yeske, 2016) .
| CONCLUSION
Mycoplasma hyopneumoniae is a very important pathogen that causes major losses to the pig industry. Research has focused on the epidemiology and transmission in different production systems, partly elucidated the very complex interaction of the pathogen with the respiratory tract, and has developed and tested many commercial and experimental vaccines. However, important knowledge gaps remain, and therefore, further research is needed to achieve a better control and possible elimination of the pathogen. The focus should be on better understanding of the virulence mechanisms and the interaction of the pathogen with the host and with other pathogens, and the development of vaccines that confer better protection and can be administered easily. Finally, research on how to successfully eliminate the pathogen from pig herds should also be stimulated.
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